CTOs on the Move

CareCentrix

www.carecentrix.com

 
CareCentrix is a leader in managing care to the home. Headquartered in Hartford, Conn., CareCentrix connects patients with the care they need at home, through a national network of over 8,000 credentialed provider locations providers, with customer care centers located across the United States. CareCentrix provides optimal access to quality home care for more than 23 million lives by connecting providers with patients and helping them navigate the complex home care system. CareCentrix`s extensive range of services provides support and coordination for patients and their families in every step of the healing process, including home health, durable medical equipment (DME), ...
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details
Matthew Mudry
Area Vice President - Information Security and Architecture Profile

Similar Companies

Flugen

FluGen is driving the development of a universal flu vaccine to advance human health.

Lincoln County Health System

The Lincoln County Health System is a full-service, health care system, which serves Lincoln County. The Lincoln County Health System is a multi-faceted health care system whose mission is to provide life-long health care for the people it serves. In addition to a 59-bed acute care hospital, the system consists of a freestanding rehabilitation and wellness center, a 240 bed licensed nursing home, a home health and hospice agency, and an ambulance/EMS service. The facilities are county-owned and are governed by the Lincoln County Health System Board of Trustees.

Petaluma Health Care District

Petaluma Health Care District is a Petaluma, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ContraVir Pharmaceuticals, Inc

ContraVir is a biopharmaceutical company focused primarily on the development of drugs to treat herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus or VZV. Our lead candidate, FV-100, is an orally available nucleoside analogue prodrug of CF-1743 that we are developing for the treatment of shingles. Published preclinical studies demonstrate that FV-100 is significantly more potent against VZV than acyclovir, valacyclovir, and famciclovir, the FDA-approved drugs used for the treatment of shingles. Preclinical studies further demonstrate that FV-100 has a more rapid onset of antiviral activity, and may fully inhibit the replication of VZV more rapidly than these drugs at significantly lower concentration levels. In addition, pharmacokinetic data from completed phase 1 and 2 clinical trials suggest that FV-100 has the potential to demonstrate antiviral activity when dosed orally once-a-day at significantly lower levels than valacyclovir, acyclovir, and famciclovir.

Golden Leaf Holdings

Built around a portfolio of recognized brands, Golden Leaf Holdings Incorporate is one of the largest cannabis oil and solution providers in North America. The Company leverages a strong management team with cannabis and food industry experience to complement its expertise in the extracting, refining and selling of cannabis oil, edibles and flower products. The Company has developed a strong consumer brand portfolio (“Golden Brands”) that includes the Golden, Proper, Chalice Farms, Liberty Reach and Jackpot Seaweed brands. In addition to leading branded products, Golden Leaf also maintains a foothold in the Oregon retail dispensary market with its award-winning chain of Chalice Farms retail stores.